Skip to main content
Clinical Trials/NL-OMON48829
NL-OMON48829
Recruiting
Phase 4

octurnal Non-Invasive ventilation in COPD patients with stable hypercapnic respiratory failure: why and in which patient might this be effective? - The effects of nocturnal non-invasive ventilation in stable COPD patients

niversitair Medisch Centrum Groningen0 sites86 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
COPD
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
86
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Indication to initiate chronic NIV in COPD patients (GOLD stage III or IV: FEV1/ forced expiratory volume (FVC)\< 70% and FEV1\< 50% predicted; PaCO2 \> 6\.0 kilopascal (kPa) in stable condition, which means no COPD exacerbation for 4 weeks and a pH \> 7\.35\)
  • Shared consent of the participant and agreement of the participant and his/her home mechanical ventilation centre doctor to start NIV
  • Age \> 18 years
  • Written informed consent is obtained

Exclusion Criteria

  • For inclusion in the prospective cohort part of the study no special exclusion criteria exist. ;For the randomised inflammation part, in which patients will undergo bronchoscopies, a potential subject who meets any of the following criteria will be excluded from participation in this study:;• The use of \>10mg oral corticosteroids or roflumilast in any dosage
  • A history of lung volume reduction surgery
  • Body mass index (BMI) \> 35 kg/m2
  • Obstructive sleep apnoea (OSA) (apnoea/hypopnea index (AHI) \>15/hr): to exclude OSA a polygraphy will be done at baseline
  • PaCO2 \>\= 8\.0 kPa or PaO2 \< 6\.5 kPa at rest without oxygen
  • Instable cardiac comorbidities (left ventricular ejection fraction (LVEF)\<40%, instable coronary artery disease, instable heart failure)

Outcomes

Primary Outcomes

Not specified

Similar Trials